RxDoctor Payments Data

Deborah Neumann, MD

Cardiovascular Disease · Huntington, NYNPI 1326151457

Payments from drug & device makers

$572in general payments, 2019–2025

Across 7 payments — averaging $81.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$141
  • E.r. Squibb & Sons, L.L.C.$123
  • Boston Scientific$122
  • Abbott$116
  • Atricure, Inc.$39
  • Bardy Diagnostics, Inc.$30

What the payments were for

  • Food & beverage$572100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic2$141
E.r. Squibb & Sons, L.L.C.1$123
Boston Scientific1$122
Abbott1$116
Atricure, Inc.1$39
Bardy Diagnostics, Inc.1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$572 in reported general payments places this provider in the 30th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York

Medicare billing

Part B allowed, 2024
$547,326
Medicare patients
1,080
Services billed
9,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban224$311,824
XareltoRivaroxaban221$286,043
MounjaroTirzepatide139$205,121
Repatha SureclickEvolocumab87$117,417
WegovySemaglutide55$97,613
OzempicSemaglutide55$70,411
Praluent PenAlirocumab19$21,911
Metoprolol Succinate655$12,150
Atorvastatin Calcium657$6,586
Rosuvastatin Calcium621$6,134
Valsartan181$5,119
SynthroidLevothyroxine Sodium70$4,819
Ezetimibe149$4,809
Levothyroxine Sodium269$4,214
Diltiazem 24hr Er (Cd)Diltiazem Hcl131$4,073

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Huntington

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →